Long Position on MEDP @ $56.75 on 8/15/2018 (Momentum)

Medpace Holdings, Inc. (MEDP) is a clinical contract research organization.

The company provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide.

The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in a range of therapeutic areas.

Its clinical development services include medical affairs, clinical trial management, feasibility and start-up study, clinical monitoring, global regulatory affairs, medical writing, biometrics, pharmacovigilance, core laboratory, and quality assurance. 

Shares have formed a bullish flag" and are on the cusp of a breakout.  Higher share prices are expected for this stock.

Entry Point: $56.75

Stop Loss: $53.90

52-Weeks Trading Range: $30.62 - $63.97

Target Price: $62.42

Updates

9/12/2018 9:35:57 AM

MEDP closed at $63.82

Position closed on 9/12/2018 at price of $63.82 with a 12.46% gain in 28 days.

Back to Portfolio